20-Dec-2021 - Universität Leipzig

Controlling the metabolism of cancer cells

Researchers discover function of succinate receptor for cancer treatment

With their altered metabolism, cancer cells grow faster than normal cells. Scientists at Leipzig University’s Faculty of Medicine have now discovered that cancer cells need the succinate receptor to control their metabolic rate. This knowledge should in future help doctors to develop treatments.

Cancer cells show unchecked rapid growth beyond tissue boundaries that is no longer stopped by normal control mechanisms. Due to this rapid growth, the metabolism of cancer cells is altered compared to that of cells that grow normally. Cancer cells use this metabolism to provide molecular building blocks and to meet their high energy needs. It has also been known for some time that metabolic intermediates activate specific receptors on the surface of cells. One such metabolite is succinate, which specifically activates a receptor found in various types of tumour.

Until now, there has been little research into whether and how this receptor influences the metabolism, and thus also the survival, of cancer cells. Scientists at Leipzig University have now discovered that cancer cells need the succinate receptor to control their metabolic rate, i.e. the consumption of oxygen and the production of energy. “Without the succinate receptor, cancer cells die because they lose control over central cellular metabolic pathways,” explained study head Dr Claudia Stäubert from the Rudolf Schönheimer Institute of Biochemistry.

Increased death of cancer cells observed

One of the characteristic changes in the metabolism of cancer cells is known as glutaminolysis – a dependence on the amino acid glutamine for energy production. By combining metabolic analyses with image-based studies to monitor cancer cell survival, the Leipzig-based scientists were able to show that cancer cells that exhibit such a dependence on glutamine depend on the function of the succinate receptor for their survival. “Knockdown of the receptor caused increased death of cancer cells. This was also detectable in combination with known therapeutics,” said Dr Stäubert.

The succinate receptor therefore represents a potential target for the development of chemotherapeutic agents for cancer treatment. Further research will need to identify relevant pharmacological inhibitors of the receptor and evaluate their potential as drugs in cancer therapy.

Facts, background information, dossiers

  • cancer cells
  • cancer
  • cell metabolism
  • receptors

More about Uni Leipzig

  • News

    Two-billion-year-old enzyme reconstructed

    Basic researchers at Leipzig University have solved a puzzle in the evolution of bacterial enzymes. By reconstructing a candidate for a special RNA polymerase as it existed about two billion years ago, they were able to explain a hitherto puzzling property of the corresponding modern enzyme ... more

    Newly discovered enzyme breaks down PET plastic in record time

    Plastic bottles, punnets, wrap – such lightweight packaging made of PET plastic becomes a problem if it is not recycled. Scientists at Leipzig University have now discovered a highly efficient enzyme that degrades PET in record time. The enzyme PHL7, which the researchers found in a compost ... more

    Heat storage: Scientists develop material that is stable, efficient and eco-friendly

    A new heat storage material could help to significantly improve the energy efficiency of buildings. Developed by researchers at Martin Luther University Halle-Wittenberg (MLU) and the University of Leipzig, it can be used to store surplus heat and release it back into the environment when n ... more

  • q&more articles

    Cell cultures in the third dimension

    For chemicals and pharmaceutical products that are brought to the market, meaningful toxicological data needs to be ascertained. While, to the present day, animal experiments play a key role in this task, the challenge is to replace them with high-validity tests carried out in organoid cell ... more

  • Authors

    Dr. Peggy Stock

    Peggy Stock, born in 1976, studied biology at the Martin Luther University of Halle-Wittenberg and received her doctorate in 2005. Since her return from a research stay at the University of Pittsburgh (USA) she has been working in the Applied Molecular Hepatology research group of Professor ... more

    Dr. Katja Schellenberg

    completed her studies for a Bachelor of Science in Molecular Biotechnology from TU Dresden before graduating from the international degree programme “Molecular Medicine” at Charité – Universitätsmedizin (Berlin) with an M.Sc. in 2009. Funded by a grant from Charité, she then completed her d ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by: